{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:21:06Z","timestamp":1790623266486,"version":"4.1.0"},"reference-count":215,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T00:00:00Z","timestamp":1625443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus that has re-emerged in recent decades, causing large-scale epidemics in many parts of the world. CHIKV infection leads to a febrile disease known as chikungunya fever (CHIKF), which is characterised by severe joint pain and myalgia. As many patients develop a painful chronic stage and neither antiviral drugs nor vaccines are available, the development of a potent CHIKV inhibiting drug is crucial for CHIKF treatment. A comprehensive summary of current antiviral research and development of small-molecule inhibitor against CHIKV is presented in this review. We highlight different approaches used for the identification of such compounds and further discuss the identification and application of promising viral and host targets.<\/jats:p>","DOI":"10.3390\/v13071307","type":"journal-article","created":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T22:02:04Z","timestamp":1625522524000},"page":"1307","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Antivirals against the Chikungunya Virus"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9794-366X","authenticated-orcid":false,"given":"Verena","family":"Battisti","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Sciences, Pharmaceutical Chemistry Division, University of Vienna, A-1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernst","family":"Urban","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Pharmaceutical Chemistry Division, University of Vienna, A-1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Langer","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Pharmaceutical Chemistry Division, University of Vienna, A-1090 Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0035-9203(55)90080-8","article-title":"An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952-53. I. Clinical features","volume":"49","author":"Robinson","year":"1955","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4269\/ajtmh.2007.76.405","article-title":"Drought-associated chikungunya emergence along coastal East Africa","volume":"76","author":"Chretien","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Vazeille, M., Moutailler, S., Coudrier, D., Rousseaux, C., Khun, H., Huerre, M., Thiria, J., Bastien Dehecq, J.-S., Fontenille, D., and Schuffenecker, I. (2007). Two Chikungunya Isolates from Two Chikungunya Isolates from the Outbreak of La Reunion (Indian Ocean) Exhibit Different Patterns of Infection in the Mosquito, Aedes albopictus. PLoS ONE, 2.","DOI":"10.1371\/journal.pone.0001168"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"20752","DOI":"10.2807\/1560-7917.ES2014.19.13.20752","article-title":"Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013","volume":"19","author":"Cassadou","year":"2014","journal-title":"Eurosurveillance"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/infdis\/jiw391","article-title":"Chikungunya: Its History in Africa and Asia and Its Spread to New Regions in 2013\u20132014","volume":"214","author":"Zeller","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(07)61779-6","article-title":"CHIKV study group. Infection with chikungunya virus in Italy: An outbreak in a temperate region","volume":"370","author":"Rezza","year":"2007","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2807\/1560-7917.ES.2017.22.39.17-00646","article-title":"Detection of a chikungunya outbreak in central Italy, August to September 2017","volume":"22","author":"Venturi","year":"2017","journal-title":"Eurosurveillance"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Delisle, E., Rousseau, C., Broche, B., Leparc-Goffart, I., L\u2019ambert, G., Cochet, A., Prat, C., Foulongne, V., Ferr\u00e9, J.B., and Catelinois, O. (2015). Chikungunya outbreak in Montpellier, France, September to October 2014. Eurosurveillance, 20.","DOI":"10.2807\/1560-7917.ES2015.20.17.21108"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2807\/1560-7917.ES.2017.22.39.17-00647","article-title":"Preliminary report of an autochthonous chikungunya outbreak in France, July to September 2017","volume":"22","author":"Calba","year":"2017","journal-title":"Eurosurveillance"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rstb.2014.0135","article-title":"Climate change influences on global distributions of dengue and chikungunya virus vectors","volume":"370","author":"Campbell","year":"2015","journal-title":"Philos. Trans. R. Soc. B Biol. Sci."},{"key":"ref_11","unstructured":"WHO Media Centre (2021, May 31). Chikungunya\u2014Key Facts. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/chikungunya."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.antiviral.2013.06.009","article-title":"Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy","volume":"99","author":"Thiberville","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1086\/590003","article-title":"Persistent arthralgia associated with chikungunya virus: A study of 88 adult patients on reunion island","volume":"47","author":"Borgherini","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3201\/eid1503.071482","article-title":"Guillain-Barr\u00e9 Syndrome after Chikungunya Infection","volume":"15","author":"Lebrun","year":"2009","journal-title":"Emerg. Infect. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s10067-017-3766-7","article-title":"Management of chikungunya arthritis","volume":"36","author":"Schoen","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/v2040796","article-title":"Alphavirus Entry and Membrane Fusion","volume":"2","author":"Kielian","year":"2010","journal-title":"Viruses"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of Chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virol.2009.07.024","article-title":"Replication cycle of chikungunya: A re-emerging arbovirus","volume":"393","author":"Solignat","year":"2009","journal-title":"Virology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00705-001-0773-3","article-title":"Composition of alphavirus-like replication complexes: Involvement of virus and host encoded proteins","volume":"147","author":"Bol","year":"2002","journal-title":"Arch Virol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e00693-16","DOI":"10.1128\/mBio.00693-16","article-title":"Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection","volume":"7","author":"Ashbrook","year":"2016","journal-title":"MBio"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2015.06.017","article-title":"Towards antivirals against chikungunya virus","volume":"121","author":"Abdelnabi","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_22","first-page":"837","article-title":"A structural and functional perspective of alphavirus replication and assembly","volume":"4","author":"Jose","year":"2009","journal-title":"Futur. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","article-title":"The alphaviruses: Gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol. Rev"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.antiviral.2011.03.182","article-title":"In vitro antiviral activity of arbidol against Chikungunya virus and characteristics of a selected resistant mutant","volume":"90","author":"Delogu","year":"2011","journal-title":"Antivir. Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Ho, Y.-J., Wang, Y.-M., Lu, J., Wu, T.-Y., Lin, L.-I., Kuo, S.-C., and Lin, C.-C. (2015). Suramin Inhibits Chikungunya Virus Entry and Transmission. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0133511"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.antiviral.2016.07.025","article-title":"Suramin treatment reduces chikungunya pathogenesis in mice","volume":"134","author":"Kuo","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.06.013","article-title":"Suramin inhibits chikungunya virus replication through multiple mechanisms","volume":"121","author":"Albulescu","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.virol.2016.08.029","article-title":"Inhibition of chikungunya virus by picolinate that targets viral capsid protein","volume":"498","author":"Sharma","year":"2016","journal-title":"Virology"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dey, D., Siddiqui, S.I., Mamidi, P., Ghosh, S., Kumar, C.S., Chattopadhyay, S., Ghosh, S., and Banerjee, M. (2019). The effect of amantadine on an ion channel protein from Chikungunya virus. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007548"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4000","DOI":"10.1021\/jm401844c","article-title":"Identification of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones as novel inhibitors of Chikungunya virus replication","volume":"57","author":"Gigante","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"31819","DOI":"10.1038\/srep31819","article-title":"The viral capping enzyme nsP1: A novel target for the inhibition of chikungunya virus infection","volume":"6","author":"Delang","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.antiviral.2017.06.003","article-title":"Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1","volume":"144","author":"Gigante","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1021\/acsinfecdis.7b00219","article-title":"Inhibition of the Replication of Different Strains of Chikungunya Virus by 3-Aryl-[1,2,3]triazolo[4,5- d]pyrimidin-7(6 H)-ones","volume":"4","author":"Gamo","year":"2018","journal-title":"ACS Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1021\/acsmedchemlett.9b00662","article-title":"Identification of 2-(4-(Phenylsulfonyl)piperazine-1-yl)pyrimidine Analogues as Novel Inhibitors of Chikungunya Virus","volume":"11","author":"Moesslacher","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00649-20","DOI":"10.1128\/AAC.00649-20","article-title":"Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery","volume":"64","author":"Abdelnabi","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.antiviral.2018.03.013","article-title":"Identification of small molecule inhibitors of the Chikungunya virus nsP1 RNA capping enzyme","volume":"154","author":"Feibelman","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"111956","DOI":"10.1016\/j.ejmech.2019.111956","article-title":"Identification of 6\u2032-\u03b2-fluoro-homoaristeromycin as a potent inhibitor of chikungunya virus replication","volume":"187","author":"Shin","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e02532-19","DOI":"10.1128\/AAC.02532-19","article-title":"6\u2032-\u03b2-Fluoro-Homoaristeromycin and 6\u2032-Fluoro-Homoneplanocin A Are Potent Inhibitors of Chikungunya Virus Replication through Their Direct Effect on Viral Nonstructural Protein 1","volume":"64","author":"Kovacikova","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/1873-3468.13642","article-title":"Inhibition of Chikungunya virus by an adenosine analog targeting the SAM-dependent nsP1 methyltransferase","volume":"594","author":"Mudgal","year":"2020","journal-title":"FEBS Lett."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2013.01.002","article-title":"Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus","volume":"98","author":"Bassetto","year":"2013","journal-title":"Antivir. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bmc.2018.01.002","article-title":"Design, synthesis and evaluation against Chikungunya virus of novel small-molecule antiviral agents","volume":"26","author":"Tardugno","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejmech.2018.02.054","article-title":"Rational modifications on a benzylidene-acrylohydrazide antiviral scaffold, synthesis and evaluation of bioactivity against Chikungunya virus","volume":"149","author":"Giancotti","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7382","DOI":"10.1128\/AAC.01421-16","article-title":"Design and Validation of Novel Chikungunya Virus Protease Inhibitors","volume":"60","author":"Das","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1087057112460091","article-title":"A phenotypic assay to identify Chikungunya virus inhibitors targeting the nonstructural protein nsP2","volume":"18","author":"Lupan","year":"2013","journal-title":"J. Biomol. Screen."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.virol.2020.05.010","article-title":"Evaluation of novobiocin and telmisartan for anti-CHIKV activity","volume":"548","author":"Tripathi","year":"2020","journal-title":"Virology"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Zhang, S., Garzan, A., Haese Id, N., Bostwick, R., Martinez-Gzegozewska, Y., Rasmussen, L., Streblow, D.N., Haise, M.T., Pathak, A.K., and Augelli-Szafran, C.E. (2021). Pyrimidone inhibitors targeting Chikungunya Virus nsP3 macrodomain by fragment-based drug design. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245013"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/jac\/dku209","article-title":"Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral","volume":"69","author":"Delang","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.antiviral.2017.09.016","article-title":"Antiviral treatment efficiently inhibits chikungunya virus infection in the joints of mice during the acute but not during the chronic phase of the infection","volume":"149","author":"Abdelnabi","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e02395-16","DOI":"10.1128\/AAC.02395-16","article-title":"Characterization of \u03b2-d-N4-Hydroxycytidine as a Novel Inhibitor of Chikungunya Virus","volume":"61","author":"Ehteshami","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e01965-17","DOI":"10.1128\/JVI.01965-17","article-title":"\u03b2-D-N4- Hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome","volume":"92","author":"Urakova","year":"2017","journal-title":"J. Virol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e01389-18","DOI":"10.1128\/AAC.01389-18","article-title":"Beyond members of the Flaviviridae family, sofosbuvir also inhibits chikungunya virus replication","volume":"63","author":"Ferreira","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.virol.2017.02.014","article-title":"Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus. Virology","volume":"505","author":"Wada","year":"2017","journal-title":"Virology"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bmc.2016.10.037","article-title":"Discovery of novel multi-target indole-based derivatives as potent and selective inhibitors of chikungunya virus replication","volume":"25","author":"Scuotto","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.antiviral.2017.08.008","article-title":"Bis(benzofuran-thiazolidinone)s and bis(benzofuran-thiazinanone)s as inhibiting agents for chikungunya virus","volume":"146","author":"Hwu","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Passos, G.F.S., Gomes, M.G.M., de Aquino, T.M., de Ara\u00fajo-J\u00fanior, J.X., de Souza, S.J.M., Cavalcante, J.P.M., Dos Santos, E.C., Bassi, \u00ca.J., and da Silva-J\u00fanior, E.F. (2020). Computer-Aided Design, Synthesis, and Antiviral Evaluation of Novel Acrylamides as Potential Inhibitors of E3-E2-E1 Glycoproteins Complex from Chikungunya Virus. Pharmaceuticals, 13.","DOI":"10.3390\/ph13070141"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.antiviral.2018.10.005","article-title":"Micafungin is a novel anti-viral agent of chikungunya virus through multiple mechanisms","volume":"159","author":"Ho","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Rothan, H.A., Bahrani, H., Mohamed, Z., Teoh, T.C., Shankar, E.M., Rahman, N.A., and Yusof, R. (2015). A Combination of Doxycycline and Ribavirin Alleviated Chikungunya Infection. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0126360"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"104808","DOI":"10.1016\/j.antiviral.2020.104808","article-title":"Alphavirus capsid protease inhibitors as potential antiviral agents for Chikungunya infection","volume":"179","author":"Fatma","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"20122","DOI":"10.1038\/srep20122","article-title":"Inhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea (MBZM-N-IBT)","volume":"6","author":"Mishra","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejmech.2014.10.042","article-title":"Thiazolidone derivatives as inhibitors of chikungunya virus","volume":"89","author":"Sinha","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/cbdd.12621","article-title":"Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors","volume":"86","author":"Ismail","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.biochi.2018.04.004","article-title":"Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease","volume":"149","author":"Singh","year":"2018","journal-title":"Biochimie"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"85938","DOI":"10.1039\/C5RA14469H","article-title":"Reaching beyond HIV\/HCV: Nelfinavir as a potential starting point for broad-spectrum protease inhibitors against dengue and chikungunya virus","volume":"5","author":"Bhakat","year":"2015","journal-title":"RSC Adv."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1016\/j.bmc.2014.09.013","article-title":"Structure\u2013activity relationship study of arbidol derivatives as inhibitors of chikungunya virus replication","volume":"22","author":"Peduto","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","article-title":"Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry","volume":"13","author":"Beck","year":"2016","journal-title":"Virol. J."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Albulescu, I.C., White-Scholten, L., Tas, A., Hoornweg, T.E., Ferla, S., Kovacikova, K., Smit, J.M., Brancale, A., Snijder, E.J., and van Hemert, M.J. (2020). Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection. Viruses, 12.","DOI":"10.3390\/v12030314"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bbrc.2017.07.157","article-title":"Synergistic effects of combination treatment using EGCG and suramin against the chikungunya virus","volume":"491","author":"Lu","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.001","article-title":"The green tea catechin, epigallocatechin gallate inhibits chikungunya virus infection","volume":"113","author":"Weber","year":"2015","journal-title":"Antivir. Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jmv.1890210113","article-title":"Suramin treatment for chronic active hepatitis B\u2014toxic and ineffective","volume":"21","author":"Loke","year":"1987","journal-title":"J. Med. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0002-9343(87)90108-2","article-title":"Lack of response to suramin in patients with AIDS and AIDS-related complex","volume":"82","author":"Kaplan","year":"1987","journal-title":"Am. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"439","DOI":"10.6026\/97320630015439","article-title":"Virtual screening of inhibitors against Envelope glycoprotein of Chikungunya Virus: A drug repositioning approach","volume":"15","author":"Agarwal","year":"2019","journal-title":"Bioinformation"},{"key":"ref_72","unstructured":"Fernandez-Pol, J.A., and Fernandez-Pol, S. (2010). Method to Control Dengue Viruses in Humans by Picolinic Acid and Derivates Thereof 2010. (12\/175,277), U.S. Patent."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.bmc.2007.01.040","article-title":"Synthesis of dioxane-based antiviral agents and evaluation of their biological activities as inhibitors of Sindbis virus replication","volume":"15","author":"Kim","year":"2007","journal-title":"Bioorganic Med. Chem."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Aggarwal, M., Tapas, S., Siwach, A., Kumar, P., Kuhn, R.J., and Tomar, S. (2012). Crystal Structure of Aura Virus Capsid Protease and Its Complex with Dioxane: New Insights into Capsid-Glycoprotein Molecular Contacts. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0051288"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.antiviral.2017.08.015","article-title":"Evaluation of antiviral activity of piperazine against Chikungunya virus targeting hydrophobic pocket of alphavirus capsid protein","volume":"146","author":"Aggarwal","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.virol.2017.12.020","article-title":"Structure-function insights into chikungunya virus capsid protein: Small molecules targeting capsid hydrophobic pocket","volume":"515","author":"Sharma","year":"2018","journal-title":"Virology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"10967","DOI":"10.1073\/pnas.0804958105","article-title":"Functional studies indicate amantadine binds to the pore of the influenza A virus M2 proton-selective ion channel","volume":"105","author":"Jing","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Cheung, J., Frankling, M., Mancia, F., Rudolph, M., Cassidy, M., Gary, E., Burshteyn, F., and Love, J. (2021, June 02). RCSB PDB\u20143TRK: Structure of the Chikungunya Virus nsP2 Protease; 2011. Available online: https:\/\/www.rcsb.org\/structure\/3TRK.","DOI":"10.2210\/pdb3trk\/pdb"},{"key":"ref_79","first-page":"1","article-title":"Promising inhibitors of nsp2 of CHIKV using molecular docking and temperature-dependent molecular dynamics simulations","volume":"21","author":"Meena","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"104668","DOI":"10.1016\/j.antiviral.2019.104668","article-title":"In silico drug repurposing for the identification of potential candidate molecules against arboviruses infection","volume":"173","author":"Espinosa","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/07391102.2020.1731602","article-title":"Discovery of small molecule inhibitors of chikungunya virus proteins (nsP2 and E1) using in silico approaches","volume":"39","author":"Khan","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Kumar, P., Kumar, D., and Giri, R. (2019). Targeting the nsp2 cysteine protease of Chikungunya virus using FDA approved library and selected Cysteine protease inhibitors. Pathogens, 8.","DOI":"10.3390\/pathogens8030128"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.12688\/f1000research.12301.2","article-title":"In silico analysis of natural compounds targeting structural and nonstructural proteins of chikungunya virus","volume":"6","author":"Jain","year":"2017","journal-title":"F1000Research"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"453","DOI":"10.4103\/0250-474X.164769","article-title":"Molecular modeling and docking study to elucidate novel chikungunya virus nsP2 protease inhibitors","volume":"77","author":"Agarwal","year":"2015","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2015.01.001","article-title":"Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches","volume":"57","author":"Nguyen","year":"2015","journal-title":"J. Mol. Graph. Model."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4172\/jpb.1000213","article-title":"Homology Modeling and Docking to Potential Novel Inhibitor for Chikungunya (37997) Protein nsP2 Protease","volume":"5","author":"Bora","year":"2012","journal-title":"J Proteomics Bioinform"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00894-011-1018-3","article-title":"Homology modeling, molecular dynamics, e-pharmacophore mapping and docking study of Chikungunya virus nsP2 protease","volume":"18","author":"Singh","year":"2012","journal-title":"J. Mol. Model."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1080\/07391102.2016.1261046","article-title":"Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease","volume":"35","author":"Dhindwal","year":"2017","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1007\/s00894-014-2216-6","article-title":"Discovery of in silico hits targeting the nsP3 macro domain of chikungunya virus","volume":"20","author":"Nguyen","year":"2014","journal-title":"J. Mol. Model."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Abu Bakar, F., and Ng, L. (2018). Nonstructural Proteins of Alphavirus\u2014Potential Targets for Drug Development. Viruses, 10.","DOI":"10.3390\/v10020071"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e00487-17","DOI":"10.1128\/JVI.00487-17","article-title":"Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase","volume":"91","author":"Abdelnabi","year":"2017","journal-title":"J. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"204020661880758","DOI":"10.1177\/2040206618807580","article-title":"The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines","volume":"26","author":"Franco","year":"2018","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"104904","DOI":"10.1016\/j.antiviral.2020.104904","article-title":"Strain-dependent disease and response to favipiravir treatment in mice infected with Chikungunya virus","volume":"182","author":"Julander","year":"2020","journal-title":"Antivir. Res."},{"key":"ref_94","first-page":"1752","article-title":"Exploring the polymerase activity of chikungunya viral non structural protein 4 (nsP4) using molecular modeling, e-pharmacophore and docking studies","volume":"3","author":"Kumar","year":"2012","journal-title":"Int. J. Pharm. Life Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/jmv.21663","article-title":"Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in Vero cells","volume":"88","author":"Khan","year":"2010","journal-title":"J. Med. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e02227-16","DOI":"10.1128\/AAC.02227-16","article-title":"Obatoclax Inhibits Alphavirus Membrane Fusion by Neutralizing the Acidic Environment of Endocytic Compartments","volume":"61","author":"Varghese","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.antiviral.2016.10.003","article-title":"Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission","volume":"135","author":"Wang","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Hua, C., Lee, R., Hussain, K.M., Jang, J., and Chuid, H. (2019). Macropinocytosis dependent entry of Chikungunya virus into human muscle cells. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007610"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"11320","DOI":"10.1038\/ncomms11320","article-title":"A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs","volume":"7","author":"Karlas","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"104642","DOI":"10.1016\/j.antiviral.2019.104642","article-title":"Fatty acid synthase and stearoyl-CoA desaturase-1 are conserved druggable cofactors of Old World Alphavirus genome replication","volume":"172","author":"Bakhache","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41598-020-58468-8","article-title":"Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against dengue virus, Japanese encephalitis virus, Zika virus and chikungunya virus","volume":"10","author":"Hitakarun","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/s41598-017-03316-5","article-title":"Imipramine Inhibits Chikungunya Virus Replication in Human Skin Fibroblasts through Interference with Intracellular Cholesterol Trafficking","volume":"7","author":"Wichit","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"e01220-19","DOI":"10.1128\/AAC.01220-19","article-title":"Inhibition of chikungunya virus replication in primary human fibroblasts by liver X receptor agonist","volume":"63","author":"Hwang","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.antiviral.2003.09.005","article-title":"In vitro inhibition of Chikungunya and Semliki Forest viruses replication by antiviral compounds: Synergistic effect of interferon-alpha and ribavirin combination","volume":"61","author":"Briolant","year":"2004","journal-title":"Antivir. Res."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2017.11.004","article-title":"Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens","volume":"149","author":"Tong","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Lucas-Hourani, M., Dauzonne, D., Jorda, P., Lle Cousin, G., Lupan, A., Helynck, O., Gory Caignard, G., Ve Janvier, G., Na\u00eb Lle Andr\u00e9 -Leroux, G., and Khiar, S. (2013). Inhibition of Pyrimidine Biosynthesis Pathway Suppresses Viral Growth through Innate Immunity. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003678"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"e00383-17","DOI":"10.1128\/AAC.00383-17","article-title":"Original chemical series of pyrimidine biosynthesis inhibitors that boost the antiviral interferon response","volume":"61","author":"Dauzonne","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/acs.jmedchem.9b00091","article-title":"Discovery, Optimization, and Target Identification of Novel Potent Broad-Spectrum Antiviral Inhibitors","volume":"62","author":"Yang","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"e00389-19","DOI":"10.1128\/JVI.00389-19","article-title":"Atovaquone Inhibits Arbovirus Replication through the Depletion of Intracellular Nucleotides","volume":"93","author":"Grande","year":"2019","journal-title":"J. Virol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.antiviral.2018.11.017","article-title":"A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses","volume":"161","author":"Hwang","year":"2019","journal-title":"Antivir. Res."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1128\/AAC.01467-12","article-title":"Inhibition of chikungunya virus replication by harringtonine, a novel antiviral that suppresses viral protein expression","volume":"57","author":"Kaur","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2018.07.005","article-title":"Repurposed FDA-Approved drug sorafenib reduces replication of Venezuelan equine encephalitis virus and other alphaviruses","volume":"157","author":"Lundberg","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Kaur, P., Lello, L.S., Utt, A., Dutta, S.K., Merits, A., and Chu, J.J.H. (2020). Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis. PLoS Negl. Trop. Dis., 14.","DOI":"10.1371\/journal.pntd.0008336"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"ofy315","DOI":"10.1093\/ofid\/ofy315","article-title":"Rev-erb Agonist Inhibits Chikungunya and O\u2019nyong\u2019nyong Virus Replication","volume":"5","author":"Hwang","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"e01446-19","DOI":"10.1128\/mBio.01446-19","article-title":"Sirtuin inhibitors are broadly antiviral against arboviruses","volume":"10","author":"Hackett","year":"2019","journal-title":"MBio"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.antiviral.2013.12.010","article-title":"Chikungunya virus nsP3 & nsP4 interacts with HSP-90 to promote virus replication: HSP-90 inhibitors reduce CHIKV infection and inflammation in vivo","volume":"103","author":"Rathore","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Barrera, M.D., Callahan, V., Akhrymuk, I., Bhalla, N., Zhou, W., Campbell, C., Narayanan, A., and Kehn-hall, K. (2021). Proteomic discovery of veev e2-host partner interactions identifies grp78 inhibitor ha15 as a potential therapeutic for alphavirus infections. Pathogens, 10.","DOI":"10.3390\/pathogens10030283"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2017.04.014","article-title":"Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential","volume":"143","author":"Langsjoen","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"13476","DOI":"10.1038\/srep13476","article-title":"Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting","volume":"5","author":"Zilbermintz","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"6346","DOI":"10.1021\/acs.jmedchem.9b00781","article-title":"Design, Synthesis, and Anti-RNA Virus Activity of 6\u2032-Fluorinated-Aristeromycin Analogues","volume":"62","author":"Yoon","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e02325-18","DOI":"10.1128\/AAC.02325-18","article-title":"Src family kinase inhibitors block translation of alphavirus subgenomic mRNAs","volume":"63","author":"Broeckel","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Cruz, D.J.M., Bonotto, R.M., Gomes, R.G.B., da Silva, C.T., Taniguchi, J.B., No, J.H., Lombardot, B., Schwartz, O., Hansen, M.A.E., and Freitas-Junior, L.H. (2013). Identification of Novel Compounds Inhibiting Chikungunya Virus-Induced Cell Death by High Throughput Screening of a Kinase Inhibitor Library. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002471"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.antiviral.2015.12.012","article-title":"Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses","volume":"126","author":"Varghese","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1128\/JVI.01382-16","article-title":"The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling","volume":"90","author":"Varghese","year":"2016","journal-title":"J. Virol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"9","DOI":"10.12688\/f1000research.13242.1","article-title":"Miltefosine inhibits Chikungunya virus replication in human primary dermal fibroblasts","volume":"7","author":"Sharma","year":"2018","journal-title":"F1000Research"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.antiviral.2016.12.020","article-title":"Protein kinases C as potential host targets for the inhibition of chikungunya virus replication","volume":"139","author":"Abdelnabi","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1021\/acs.jnatprod.5b01016","article-title":"Simplified Bryostatin Analogues Protect Cells from Chikungunya Virus-Induced Cell Death","volume":"79","author":"Staveness","year":"2016","journal-title":"J. Nat. Prod."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1021\/acs.jnatprod.5b01017","article-title":"Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway","volume":"79","author":"Staveness","year":"2016","journal-title":"J. Nat. Prod."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"6178","DOI":"10.1021\/acs.jmedchem.8b00613","article-title":"Optimization of Isothiazolo[4,3-b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity","volume":"61","author":"Pu","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"9683","DOI":"10.1128\/JVI.01347-16","article-title":"Inhibition of Polyamine Biosynthesis Is a Broad-Spectrum Strategy against RNA Viruses","volume":"90","author":"Mounce","year":"2016","journal-title":"J. Virol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.antiviral.2014.09.007","article-title":"Antiviral activity of lanatoside C against dengue virus infection","volume":"111","author":"Cheung","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"M\u00fcller, M., Slivinski, N., Todd, E.J.A.A., Khalid, H., Li, R., Karwatka, M., Merits, A., Mankouri, J., and Tuplin, A. (2019). Chikungunya virus requires cellular chloride channels for efficient genome replication. PLoS Negl. Trop. Dis., 13.","DOI":"10.1371\/journal.pntd.0007703"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"e00274-20","DOI":"10.1128\/JVI.00274-20","article-title":"Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway","volume":"94","author":"Bouma","year":"2020","journal-title":"J. Virol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1128\/JVI.00739-15","article-title":"Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry","volume":"89","author":"Mainou","year":"2015","journal-title":"J. Virol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e00440-20","DOI":"10.1128\/AAC.00440-20","article-title":"Tilorone, a broad-spectrum antiviral for emerging viruses","volume":"64","author":"Ekins","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"e01913-17","DOI":"10.1128\/JVI.01913-17","article-title":"Emerging Alphaviruses Are Sensitive to Cellular States Induced by a Novel Small-Molecule Agonist of the STING Pathway","volume":"92","author":"Gall","year":"2017","journal-title":"J. Virol."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Sali, T.M., Pryke, K.M., Abraham, J., Liu, A., Archer, I., Broeckel, R., Staverosky, J.A., Smith, J.L., Al-Shammari, A., and Amsler, L. (2015). Characterization of a Novel Human-Specific STING Agonist that Elicits Antiviral Activity Against Emerging Alphaviruses. PLoS Pathog., 11.","DOI":"10.1371\/journal.ppat.1005324"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"e00452-17","DOI":"10.1128\/mBio.00452-17","article-title":"A novel agonist of the trif pathway induces a cellular state refractory to replication of Zika, Chikungunya, and dengue viruses","volume":"8","author":"Pryke","year":"2017","journal-title":"MBio"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"8063","DOI":"10.1128\/JVI.00224-15","article-title":"Pentosan Polysulfate: A Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease","volume":"89","author":"Herrero","year":"2015","journal-title":"J. Virol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e01959-17","DOI":"10.1128\/AAC.01959-17","article-title":"Prophylactic antiheparanase activity by PG545 is antiviral in vitro and protects against Ross River virus disease in mice","volume":"62","author":"Supramaniam","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1128\/AAC.00100-12","article-title":"Sontochin as a guide to the development of drugs against chloroquine-resistant malaria","volume":"56","author":"Pou","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1099\/0022-1317-4-2-203","article-title":"Comparison of the Antiviral Activity in vitro of some Non-steroidal Anti-inflammatory Drugs","volume":"4","author":"Inglot","year":"1969","journal-title":"J. Gen. Virol"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF01250299","article-title":"Effect of chloroquine on the growth of animal viruses","volume":"36","author":"Shimizu","year":"1972","journal-title":"Arch. Gesamte Virusforsch."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1099\/0022-1317-58-1-47","article-title":"Inhibition of Semliki Forest Virus Penetration by Lysosomotropic Weak Bases","volume":"58","author":"Helenius","year":"1982","journal-title":"J. Gen. Virol"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1128\/jvi.52.3.857-864.1984","article-title":"Effects of lysosomotropic weak bases on infection of BHK-21 cells by Sindbis virus","volume":"52","author":"Cassell","year":"1984","journal-title":"J. Virol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/ard.19.3.243","article-title":"Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year","volume":"19","author":"Freedman","year":"1960","journal-title":"Ann. Rheum. Dis"},{"key":"ref_147","first-page":"217","article-title":"Chloroquine phosphate treatment of chronic Chikungunya arthritis An open pilot study","volume":"66","author":"Brighton","year":"1984","journal-title":"S. Afr. Med. J."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/vbz.2008.0049","article-title":"On Chikungunya Acute Infection and Chloroquine Treatment","volume":"8","author":"Boisson","year":"2008","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Thiberville, S.D., Boisson, V., Gaudart, J., Simon, F., Flahault, A., and de Lamballerie, X. (2013). Chikungunya Fever: A Clinical and Virological Investigation of Outpatients on Reunion Island, South-West Indian Ocean. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002004"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.38221","article-title":"Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection","volume":"66","author":"Chopra","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cmi.2020.05.016","article-title":"Systematic review Clinical evidence for repurposing chloroquine and hydroxychloroquine as antiviral agents: A systematic review","volume":"26","author":"Rodrigo","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Roques, P., Thiberville, S.D., Dupuis-Maguiraga, L., Lum, F.M., Labadie, K., Martinon, F., Gras, G., Lebon, P., Ng, L.F.P., and de Lamballerie, X. (2018). Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection. Viruses, 10.","DOI":"10.3390\/v10050268"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"21899","DOI":"10.1074\/jbc.M802444200","article-title":"Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: Impairment of the maturation of the E2 surface glycoprotein","volume":"283","author":"Ozden","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Faraone, I., Labanca, F., Ponticelli, M., De Tommasi, N., and Milella, L. (2020). Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: A Systematic Review. Molecules, 25.","DOI":"10.3390\/molecules25225318"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0973-3698(10)60189-6","article-title":"Comparative evaluation of four therapeutic regimes in Chikungunya arthritis: A prospective randomized parallel-group study","volume":"4","author":"Padmakumar","year":"2009","journal-title":"Indian J. Rheumatol."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1007\/s10067-016-3429-0","article-title":"Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: A 24-week randomized controlled open label study","volume":"36","author":"Ravindran","year":"2017","journal-title":"Clin. Rheumatol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0973-3698(10)60125-2","article-title":"Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis: A 16 week study","volume":"3","author":"Pandya","year":"2008","journal-title":"Indian J. Rheumatol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jbspin.2017.01.014","article-title":"Rheumatic manifestations associated with Chikungunya virus infection: A study of 307 patients with 32-month follow-up (RHUMATOCHIK study)","volume":"85","author":"Bouquillard","year":"2018","journal-title":"Jt. Bone Spine"},{"key":"ref_159","doi-asserted-by":"crossref","unstructured":"Sourisseau, M., Schilte, C., Casartelli, N., Trouillet, C., Guivel-Benhassine, F., Rudnicka, D., Sol-Foulon, N., Le Roux, K., Prevost, M.-C., and Fsihi, H. (2007). Characterization of Reemerging Chikungunya Virus. PLoS Pathog., 3.","DOI":"10.1371\/journal.ppat.0030089"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1006\/viro.1996.8340","article-title":"Entry of Semliki forest virus into cells: Effects of concanamycin A and nigericin on viral membrane fusion and infection","volume":"227","author":"Irurzun","year":"1997","journal-title":"Virology"},{"key":"ref_161","doi-asserted-by":"crossref","unstructured":"Jurgeit, A., Mcdowell, R., Moese, S., Meldrum, E., and Schwendener, R. (2012). Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002976"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1083\/jcb.200908086","article-title":"Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling","volume":"188","author":"Koivusalo","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/med.20104","article-title":"Inosine monophosphate dehydrogenase (IMPDH) as a target in drug discovery","volume":"28","author":"Shu","year":"2008","journal-title":"Med. Res. Rev."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2147\/CEOR.S60710","article-title":"Respiratory syncytial virus: Current and emerging treatment options","volume":"6","author":"Turner","year":"2014","journal-title":"Clin. Outcomes Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.coviro.2011.10.030","article-title":"Ribavirin for the treatment of chronic hepatitis C virus infection: A review of the proposed mechanisms of action","volume":"1","author":"Paeshuyse","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/infdis\/jiw358","article-title":"Chikungunya Virus: In Vitro Response to Combination Therapy With Ribavirin and Interferon Alfa 2a","volume":"214","author":"Gallegos","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.antiviral.2016.01.006","article-title":"Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo","volume":"127","author":"Rothan","year":"2016","journal-title":"Antivir. Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3855\/T2.2.140","article-title":"Ribavirin therapy for Chikungunya arthritis","volume":"2","author":"Ravichandran","year":"2008","journal-title":"J. Infect. Dev. Ctries."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.tet.2017.12.053","article-title":"A reassessment of mycophenolic acid as a lead compound for the development of inhibitors of chikungunya virus replication","volume":"74","author":"Rashad","year":"2018","journal-title":"Tetrahedron"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2010.10.009","article-title":"Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells","volume":"89","author":"Khan","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.1977.tb21977.x","article-title":"Antiviral Action and Selectivity of 6-Azauridine","volume":"284","author":"Rada","year":"1977","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000251329","article-title":"The treatment of psoriasis with azaribine","volume":"151","author":"Deneau","year":"1975","journal-title":"Dermatologica"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2133.1975.tb03059.x","article-title":"Double-blind controlled crossover high-dose study of Azaribine in psoriasis","volume":"92","author":"Cruthcher","year":"1975","journal-title":"Br. J. Dermatol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Raveh, A., Delekta, P.C., Dobry, C.J., Peng, W., Schultz, P.J., Blakely, P.K., Tai, A.W., Matainaho, T., Irani, D.N., and Sherman, D.H. (2013). Discovery of Potent Broad Spectrum Antivirals Derived from Marine Actinobacteria. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082318"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1038\/ncomms12308","article-title":"The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia","volume":"7","author":"Ashton","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nchembio.790","article-title":"Halofuginone and other febrifugine derivatives inhibit prolyl-tRNA synthetase","volume":"8","author":"Keller","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1432-1033.1977.tb11256.x","article-title":"Inhibition of Translation in Eukaryotic Systems by Harringtonine","volume":"72","author":"Fresno","year":"1977","journal-title":"Eur. J. Biochem."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.1046\/j.0014-2956.2001.02478.x","article-title":"Phosphorylation of eukaryotic initiation factor 4E (eIF4E) at Ser209 is not required for protein synthesis in vitro and in vivo","volume":"268","author":"McKendrick","year":"2001","journal-title":"Eur. J. Biochem."},{"key":"ref_179","doi-asserted-by":"crossref","unstructured":"Henss, L., Scholz, T., Gr\u00fcnweller, A., Schnierle, B., Henss, L., Scholz, T., Gr\u00fcnweller, A., and Schnierle, B.S. (2018). Silvestrol Inhibits Chikungunya Virus Replication. Viruses, 10.","DOI":"10.3390\/v10110592"},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1111\/jcmm.15360","article-title":"Natural antiviral compound silvestrol modulates human monocyte-derived macrophages and dendritic cells","volume":"24","author":"Blum","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coviro.2015.09.005","article-title":"Interplay between the virus and the ubiquitin-proteasome system: Molecular mechanism of viral pathogenesis","volume":"17","author":"Luo","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.bbamcr.2011.11.007","article-title":"Broad action of Hsp90 as a host chaperone required for viral replication","volume":"1823","author":"Geller","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Das, I., Basantray, I., Mamidi, P., Nayak, T.K., Pratheek, B.M., Chattopadhyay, S., and Chattopadhyay, S. (2014). Heat Shock Protein 90 Positively Regulates Chikungunya Virus Replication by Stabilizing Viral Non-Structural Protein nsP2 during Infection. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0100531"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Izumida, M., Hayashi, H., Tanaka, A., and Kubo, Y. (2020). Cathepsin B Protease Facilitates Chikungunya Virus Envelope Protein-Mediated Infection Via Endocytosis or Macropinocytosis. Viruses, 12.","DOI":"10.3390\/v12070722"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1128\/JVI.73.8.6299-6306.1999","article-title":"The Furin Protease Cleavage Recognition Sequence of Sindbis Virus PE2 Can Mediate Virion Attachment to Cell Surface Heparan Sulfate","volume":"73","author":"Klimstra","year":"1999","journal-title":"J. Virol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1128\/jvi.70.3.2069-2073.1996","article-title":"Differential Processing of Sindbis Virus Glycoprotein PE2 in Cultured Vertebrate and Arthropod Cells","volume":"70","author":"Heidner","year":"1996","journal-title":"J. Virol."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1128\/JVI.77.5.2981-2989.2003","article-title":"Furin Processing and Proteolytic Activation of Semliki Forest Virus","volume":"77","author":"Zhang","year":"2003","journal-title":"J. Virol."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cmdc.201700108","article-title":"Elongated and Shortened Peptidomimetic Inhibitors of the Proprotein Convertase Furin","volume":"12","author":"Hardes","year":"2017","journal-title":"ChemMedChem"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/jm00109a001","article-title":"S-Adenosyl-L-homocysteine Hydrolase as a Target for Antiviral Chemotherapy","volume":"34","author":"Wolfe","year":"1991","journal-title":"J. Med. Chem."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/rmv.722","article-title":"Phosphorylation events during viral infections provide potential therapeutic targets","volume":"22","author":"Keating","year":"2012","journal-title":"Rev. Med. Virol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"e01382-20","DOI":"10.1128\/mBio.01382-20","article-title":"Berberine chloride is an alphavirus inhibitor that targets nucleocapsid assembly","volume":"11","author":"Wan","year":"2020","journal-title":"MBio"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1021\/np300637t","article-title":"Prostratin and 12-O-Tetradecanoylphorbol 13-Acetate Are Potent and Selective Inhibitors of Chikungunya Virus Replication","volume":"75","author":"Bourjot","year":"2012","journal-title":"J. Nat. Prod."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bcp.2016.09.020","article-title":"Comparative analysis of the anti-chikungunya virus activity of novel bryostatin analogs confirms the existence of a PKC-independent mechanism","volume":"120","author":"Abdelnabi","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.chom.2016.06.011","article-title":"Interferon-Induced Spermidine-Spermine Acetyltransferase and Polyamine Depletion Restrict Zika and Chikungunya Viruses","volume":"20","author":"Mounce","year":"2016","journal-title":"Cell Host Microbe"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"e00344-17","DOI":"10.1128\/JVI.00344-17","article-title":"Chikungunya Virus Overcomes Polyamine Depletion by Mutation of nsP1 and the Opal Stop Codon To Confer Enhanced Replication and Fitness","volume":"91","author":"Mounce","year":"2017","journal-title":"J. Virol."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1099\/jgv.0.000712","article-title":"Viral dependence on cellular ion channels\u2014An emerging antiviral target?","volume":"98","author":"Hover","year":"2017","journal-title":"J. Gen. Virol."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"e00841-19","DOI":"10.1128\/JVI.00841-19","article-title":"Distinct Roles of Interferon Alpha and Beta in Controlling Chikungunya Virus Replication and Modulating Neutrophil-Mediated Inflammation","volume":"94","author":"Cook","year":"2019","journal-title":"J. Virol."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1126\/science.169.3951.1213","article-title":"Tilorone hydrochloride: An orally active antiviral agent","volume":"169","author":"Krueger","year":"1970","journal-title":"Science"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1743-422X-9-114","article-title":"Poly (I:C), an agonist of toll-like receptor-3, inhibits replication of the Chikungunya virus in BEAS-2B cells","volume":"9","author":"Li","year":"2012","journal-title":"Virol. J."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.virusres.2014.05.010","article-title":"TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus","volume":"189","author":"Priya","year":"2014","journal-title":"Virus Res."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1128\/JVI.79.5.2910-2919.2005","article-title":"Synthetic Double-Stranded RNA Poly(I:C) Combined with Mucosal Vaccine Protects against Influenza Virus Infection","volume":"79","author":"Ichinohe","year":"2005","journal-title":"J. Virol."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"10612","DOI":"10.1128\/JVI.01526-15","article-title":"Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant","volume":"89","author":"Beljanski","year":"2015","journal-title":"J. Virol."},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Goulet, M.-L., Olagnier, D., Xu, Z., Paz, S., Belgnaoui, S.M., Lafferty, E.I., Janelle, V., Arguello, M., Paquet, M., and Ghneim, K. (2013). Systems Analysis of a RIG-I Agonist Inducing Broad Spectrum Inhibition of Virus Infectivity. PLoS Pathog., 9.","DOI":"10.1371\/annotation\/8fa70b21-32e7-4ed3-b397-ab776b5bbf30"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1128\/JVI.03114-13","article-title":"Inhibition of Dengue and Chikungunya Virus Infections by RIG-I-Mediated Type I Interferon-Independent Stimulation of the Innate Antiviral Response","volume":"88","author":"Olagnier","year":"2014","journal-title":"J. Virol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.1128\/JVI.00845-15","article-title":"Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists","volume":"89","author":"Chiang","year":"2015","journal-title":"J. Virol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.1172\/JCI63120","article-title":"Viperin restricts chikungunya virus replication and pathology","volume":"122","author":"Teng","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"e201900298","DOI":"10.26508\/lsa.201900298","article-title":"Viperin controls chikungunya virus-specific pathogenic T cell IFN\u03b3 Th1 stimulation in mice","volume":"2","author":"Carissimo","year":"2019","journal-title":"Life Sci. Alliance"},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s40425-018-0363-5","article-title":"Immunomodulatory activities of pixatimod: Emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors","volume":"6","author":"Hammond","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s41416-018-0006-0","article-title":"A Phase i study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours","volume":"118","author":"Dredge","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_210","doi-asserted-by":"crossref","unstructured":"Krishnan, R., Duiker, M., Rudd, P.A., Skerrett, D., D Pollard, J.G., Siddel, C., Rifat, R., K Ng, J.H., Georgius, P., and Hererro, L.J. (2021). Pentosan polysulfate sodium for Ross River virus-induced arthralgia: A phase 2a, randomized, double-blind, placebo-controlled study. BMC Musculoskelet. Disord., 1.","DOI":"10.1186\/s12891-021-04123-w"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"126881","DOI":"10.1016\/j.bmcl.2019.126881","article-title":"Quinolone-N-acylhydrazone hybrids as potent Zika and Chikungunya virus inhibitors","volume":"30","author":"Marra","year":"2020","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"9196","DOI":"10.1021\/acs.jmedchem.5b01047","article-title":"Trisubstituted Thieno[3,2-b]pyrrole 5-Carboxamides as Potent Inhibitors of Alphaviruses","volume":"58","author":"Ching","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1021\/acs.jmedchem.7b00180","article-title":"Structural Optimizations of Thieno[3,2-b]pyrrole Derivatives for the Development of Metabolically Stable Inhibitors of Chikungunya Virus","volume":"60","author":"Ching","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1039\/D0RA00257G","article-title":"Regioselective convergent synthesis of 2-arylidene thiazolo[3,2- a] pyrimidines as potential anti-chikungunya agents","volume":"10","author":"Fares","year":"2020","journal-title":"RSC Adv."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.antiviral.2015.03.013","article-title":"Benzouracil\u2013coumarin\u2013arene conjugates as inhibiting agents for chikungunya virus","volume":"118","author":"Hwu","year":"2015","journal-title":"Antivir. Res."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/7\/1307\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:26:18Z","timestamp":1760163978000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/13\/7\/1307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,5]]},"references-count":215,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["v13071307"],"URL":"https:\/\/doi.org\/10.3390\/v13071307","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,5]]}}}